Home / Blog / Asia Pacific

India–Korea Cross-Border M&A: 2026 Dealmaker's Guide

Korean investment in India and Indian acquisitions in Korea are accelerating. This guide covers active sectors, buyer profiles, regulation, and deal structure.

The India–Korea M&A Corridor in 2026

India and South Korea are natural M&A partners, yet the bilateral deal corridor remains underdeveloped relative to the scale of economic ties between the two countries. Bilateral trade exceeded $25 billion in 2024, South Korea is India’s sixth-largest trading partner, and Korean investment into India grew at approximately 12% year-on-year across 2023–2025. Yet cross-border M&A activity between the two countries remains a fraction of what economics would predict.

That is beginning to change. Korean corporates — facing succession pressure, a government mandate to improve capital efficiency, and saturating domestic markets — are increasingly looking to India as a growth market. Simultaneously, Indian companies with scale ambitions in technology, pharmaceuticals, and manufacturing are evaluating Korean acquisition targets for their technology depth, manufacturing quality, and global supply chain access.

For advisory teams and deal professionals working in the APAC region, the India–Korea corridor offers genuine, undiscovered deal flow. This guide provides the practical framework for identifying opportunities, understanding the deal dynamics, and navigating the regulatory and structural requirements specific to this corridor.

Why India and Korea Are Converging in M&A

Several structural forces are pulling Indian and Korean M&A activity together.

Korea’s Outbound Imperative

South Korea’s corporate landscape is undergoing a fundamental reset. The government’s Corporate Value-Up Program is pressuring chaebol subsidiaries and listed companies to improve capital efficiency, divest non-core assets, and grow shareholder returns. For Korean corporates with significant cash positions and growth mandates, India’s $3.7 trillion economy — growing at 6–7% annually — represents one of the few markets large enough to move the needle.

Korean industrial companies (automotive, chemicals, electronics components) are increasingly reliant on Indian manufacturing partners. Korean financial services firms are evaluating India’s under-penetrated consumer financial services market. And Korean technology companies — particularly in semiconductor, display, and software — are looking at Indian IT services firms as delivery capacity partners or acquisition targets that bring skilled engineering talent at scale.

India’s Outbound Capital and Acquisition Appetite

Indian corporates with international expansion mandates are evaluating Korean assets differently from a decade ago. Korean manufacturing quality — in automotive components, specialty chemicals, precision engineering, and advanced materials — is directly relevant to Indian companies scaling globally. Indian pharmaceutical companies, already dominant in generics, are looking at Korean biopharma and biosimilar capabilities as an upgrade path into higher-margin biologics.

Indian IT services firms, which have historically grown organically, are now exploring Korean technology acquisitions to deepen capabilities in semiconductor design services, AI engineering, and embedded software — areas where Korea has world-class clusters.

“The India–Korea corridor is one of the most underserved bilateral M&A markets in Asia. The economic complementarity is obvious — Korean manufacturing depth plus Indian talent scale plus India’s domestic consumption growth — but the deal infrastructure connecting the two markets is thin. Advisors who build origination capability here before the corridor matures will be well-positioned.” — Daniel Bae, Founder & CEO, Amafi

Complementary Strengths, Limited Overlap

Unlike some bilateral corridors where buyer and seller compete in the same sector, India and Korea’s comparative advantages are largely complementary:

  • Korea excels in advanced manufacturing, semiconductors, display technology, consumer electronics, and automotive components
  • India excels in IT services, pharmaceutical formulations, business process services, and consumer market scale
  • Neither country has deep domestic alternatives for the other’s core strengths

This complementarity reduces competitive sensitivity in cross-border transactions and makes bilateral deals commercially rational for both sides.

Active Sectors for India–Korea Cross-Border M&A

Technology and IT Services

The largest opportunity in the India–Korea corridor is the intersection of Korean technology depth and Indian IT scale.

Korean technology companies — Samsung, SK Hynix, LG, Kakao, Naver, and a rich ecosystem of mid-cap software and engineering firms — are under pressure to build global delivery capacity and reduce cost structures. Indian IT services companies (Tata Consultancy, Infosys, Wipro, HCL, and dozens of mid-cap firms) are the natural counterparts. Acquisitions in this direction typically take the form of Korean companies acquiring Indian IT services boutiques (often in the $50M–$300M range) to build delivery capability in AI engineering, embedded software, or semiconductor design services.

The reverse flow — Indian technology companies acquiring Korean software or AI capabilities — is less common but growing. Indian SaaS companies expanding into the Korean enterprise market are evaluating Korean technology acquisitions to accelerate regulatory compliance capability and local market distribution.

Pharmaceuticals and Biopharma

India’s pharmaceutical industry — the world’s third-largest by volume, dominant in generic formulations — and Korea’s emerging strength in biosimilars and biologics manufacturing create a natural bilateral acquisition logic.

Korean pharmaceutical companies (Samsung Biologics, Celltrion, Hanmi, Boryung) are acquiring Indian generic platforms and API manufacturers to diversify product pipelines and distribution reach. Indian pharmaceutical companies (Dr Reddy’s, Sun Pharma, Cipla, Divi’s Laboratories) are evaluating Korean biosimilar and biologics capabilities as a path to higher-margin product segments. This is one of the most active and deal-ready sectors in the corridor.

Electric Vehicle and Advanced Materials Supply Chain

Korea’s dominance in EV battery technology (LG Energy Solution, Samsung SDI, SK On), battery materials (POSCO), and automotive components intersects directly with India’s rapidly growing EV manufacturing sector. Korean companies need Indian production bases to serve global automotive supply chains; Indian EV manufacturers need Korean technology partnerships and supply agreements.

This sector generates both strategic acquisitions and JV structures — which are often preludes to M&A — and is expected to see increasing deal activity across 2026–2027.

Financial Services and Fintech

India’s under-penetrated consumer financial services market — with $1.5 billion unbanked or underbanked adults — and its globally distinctive fintech infrastructure (UPI, Aadhaar, account aggregator framework) are attracting Korean financial groups looking for international growth platforms. KB Financial, Shinhan, Woori, and Hana Financial Group have all deepened Indian market engagement in recent years.

Korean financial groups are evaluating acquisitions in Indian NBFC platforms, insurance companies, and fintech infrastructure. The deal structures in financial services are more complex due to regulatory overlay (RBI, IRDAI), but the strategic rationale is strong.

Consumer Goods

India’s 1.4 billion-person consumer market is a primary growth destination for Korean consumer companies. K-beauty and K-food brands are capturing share in India’s urban consumer market, and Korean conglomerates — LG, Samsung consumer, CJ Foods, Orion — are evaluating acquisition-led market entry strategies alongside organic distribution builds.

For Indian consumer companies, Korean acquisitions are less common but emerging in premium beauty, functional food, and health supplement categories.

Korean Buyer Universe in India

Understanding who is buying is foundational to deal origination in this corridor.

Chaebol Strategic Acquirers: Samsung, LG, Hyundai, SK, Lotte, CJ, Hanwha, and their subsidiaries are the most active strategic acquirers. These groups have significant balance sheets and clear strategic rationale for Indian acquisitions in technology services, automotive supply chain, energy, and consumer. The challenge is navigating chaebol decision-making processes, which are more centralised and slower than Western corporate M&A.

Korean Private Equity: MBK Partners, Hahn & Company, IMM Private Equity, VIG Partners, and STIC Investments are the primary domestic PE funds. These firms are increasingly active on cross-border transactions, including taking Indian portfolio companies with Korean buyer interest through sale processes, and backing Indian-market expansions for Korean portfolio companies.

Korean Mid-Cap Industrials and Technology Companies: Below the chaebol level, Korea has a deep ecosystem of mid-cap companies (often in the KRW 500B–5T range) that are dominant in niche manufacturing, software, and specialty chemicals. These companies are often looking for acquisitions in the $50M–$200M range in India — a sweet spot for boutique advisors.

Korean Family Offices and Multi-Family Offices: Korea’s wealthy families — including second and third-generation chaebol family members managing independent family office portfolios — are increasingly active in direct private equity and real estate acquisitions in India.

Indian Buyer Universe in Korea

Indian Conglomerates: Tata Group, Mahindra & Mahindra, Reliance Industries, and Adani Group have the capital and strategic rationale for Korean acquisitions. Historical examples include Tata Motors’ familiarity with global manufacturing acquisitions and Tata Consultancy’s ongoing technology capability investments.

Indian Pharmaceutical Companies: The most systematically active Indian buyers in Korea are pharmaceutical companies. Dr Reddy’s, Sun Pharma, Cipla, and Divi’s Labs have active business development teams evaluating Korean biopharma and biosimilar assets.

Indian IT Services Companies: HCL Technologies, Wipro, and mid-size IT services firms are evaluating Korean technology acquisitions to deepen AI and semiconductor-adjacent capabilities.

Indian Private Equity: India-focused PE funds (Warburg Pincus India, Blackstone India, KKR India) are less active in Korean acquisitions but are evaluating Korean manufacturing assets that complement Indian portfolio companies.

Regulatory Framework: India Side

FEMA and Foreign Investment

For Korean companies acquiring Indian businesses, foreign direct investment flows under the Foreign Exchange Management Act (FEMA). Most sectors are under the automatic route — Korean companies can invest up to 100% equity without prior government approval. Sectors requiring government approval include defence, media, and insurance. The Department for Promotion of Industry and Internal Trade (DPIIT) administers the FDI framework.

Competition Commission of India (CCI)

Transactions meeting threshold deal values (combined global assets exceeding INR 10 billion or global turnover exceeding INR 30 billion) require CCI merger notification. CCI review typically takes 30–120 days for non-complex transactions. Korean acquirers entering India should plan for CCI approval as a deal timeline input, particularly for acquisitions of mid-size companies.

Reserve Bank of India (RBI)

For Indian companies making outbound acquisitions in Korea, the Overseas Direct Investment (ODI) framework under FEMA requires RBI notification. ODI is permitted up to 400% of net worth through the automatic route. The funding can come from foreign currency accounts, foreign currency borrowings, or remittance of foreign exchange. More recent FEMA amendments have streamlined the ODI process for well-capitalised Indian companies.

Regulatory Framework: Korea Side

KFTC Merger Notification

The Korea Fair Trade Commission (KFTC) requires merger notification for transactions where one party’s worldwide turnover exceeds KRW 300 billion and the other party’s Korean turnover exceeds KRW 30 billion. KFTC review timelines for routine transactions are 30 days; complex transactions are reviewed within 90 days. The Korean competition review process has become more predictable under recent administrations.

FEFTA National Security Review

Korea’s Foreign Exchange Transactions Act (FEFTA) includes a national security screening mechanism for inbound investments in designated strategic industries — semiconductors, display technology, secondary batteries, advanced materials, defence, and critical infrastructure. Indian acquirers evaluating Korean technology companies in these sectors should factor FEFTA review into deal timelines.

Korea-India DTAA

Korea and India maintain a Double Taxation Avoidance Agreement (DTAA, signed 1985, updated) that provides reduced withholding tax rates on dividends (15% or 5% depending on ownership threshold) and an exemption or reduced rate framework for capital gains. The DTAA significantly influences deal structuring, particularly for transactions involving holding companies in treaty jurisdictions.

Deal Structuring Considerations

Valuation Approaches: Indian company valuations in cross-border transactions typically reference EBITDA multiples, DCF, and comparable transaction analysis, consistent with global M&A practice. Korean buyers often struggle with Indian private company valuation uncertainty (financial reporting quality varies significantly) and frequently require independent valuation reports — which are also mandated by FEMA for regulated inbound FDI.

Korean company valuations often carry a structural discount (the “Korea Discount”) relative to comparable global peers, driven by complex corporate structures, related-party transaction concerns, and historically below-market shareholder returns. Foreign acquirers can benefit from this discount if they have the governance capability to improve the acquired company’s capital efficiency.

Payment Structures: All-cash transactions are common in Korean acquisitions of Indian targets. Earnout structures are more common in India, reflecting the growth profile of Indian acquisition targets and the buyer’s desire to align incentives around future performance. Korean sellers in PE-backed transactions typically prefer clean exit structures.

Currency Considerations: Indian Rupee is a partially convertible currency. Korean buyers must understand the repatriation mechanics of dividends and sale proceeds under FEMA. Hedging the Indian Rupee / Korean Won exposure over deal timelines of 6–24 months is a meaningful structuring consideration.

Origination Strategies for the India–Korea Corridor

Identifying deal targets in the India–Korea corridor requires different approaches on each side.

For Korean buyers looking for Indian targets: The Indian private company universe is large (800,000+ registered companies) but opaque — financial reporting quality varies, company registers are fragmented across state and central databases, and private market data coverage is patchy. PrivyLogic provides structured APAC private company intelligence that covers Indian company financial data, ownership, and industry context. AI-augmented buyer matching — scoring Indian companies against Korean acquirer buy-boxes — reduces the target identification workload from weeks to days.

For Indian buyers looking for Korean targets: Korea’s company registry (HTS, DART) is well-maintained for listed companies, but private company data requires relationship-based origination or specialist data services. Engagement with Korean M&A advisory boutiques, accountants, and corporate brokers is the primary sourcing channel for Korean SME and mid-market targets.

For advisors running bilateral processes: The most effective approach is AI-augmented origination that spans both company registries, combined with relationship-based deal introduction through networks in both markets. Amafi provides origination support for advisory teams running India–Korea processes, covering target identification, pitchbook and CIM preparation, and deal process support delivered to partner advisors on a fee-share basis.

Key Advisors in the India–Korea Corridor

The advisory landscape for India–Korea cross-border M&A is thin. Most regional advisory firms have strength on one side of the corridor but not both. Effective execution of India–Korea deals typically requires a combination of:

  • A Korea-capable advisor (with Korean-language ability and chaebol relationship access)
  • An India-capable advisor (with FEMA expertise, CCI process knowledge, and domestic company relationships)
  • A coordinating principal or independent advisor with cross-border structuring capability

The major investment banks (Goldman, Morgan Stanley, UBS, HSBC, Nomura, MUFG) cover mega-cap India–Korea transactions. The mid-market — deals in the $50M–$500M range — is underserved by purpose-built advisors.

Daniel Bae

About the author

Daniel Bae

Co-founder & CEO, Amafi

Daniel is an investment banker with 15+ years of experience in M&A, having advised on deals worth over US$30 billion. His career spans Citi, Moelis, Nomura, and ANZ across London, Hong Kong, and Sydney. He holds a combined Commerce/Law degree from the University of New South Wales. Daniel founded Amafi to solve the pain points in M&A, enabling bankers to focus on what matters most — delivering trusted advice to clients.